Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Cutaquig provided safe and effective dosing flexibility for patients with primary immunodeficiency ...
Implementation of an Extended-infusion Piperacillin–Tazobactam Program at an Urban Teaching Hospital
We successfully converted the administration of piperacillin–tazobactam from a 30-minute infusion given every 4–6 hours to an extended 4-hour infusion of 3.375 g repeated every 8 or 12 hours for ...
The expanded approval was based on the single-arm, non-randomized, open-label phase 4 PETITE-T1D study, which evaluated the safety and pharmacokinetics of teplizumab.
The Alzheimer's treatment Leqembi is prepared at Abington Neurological Associates in Abington, PA., on November 7, 2023. The medicine is now available in a self-injecting pen, Leqembi Iqlik. Credit - ...
TOKYO and CAMBRIDGE, Mass., Sept 25, 2023 - (JCN Newswire) - - Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti- soluble aggregated amyloid-beta (Abeta) monoclonal antibody "LEQEMBI ...
AbbVie Inc. said Thursday the Food and Drug Administration has approved its vyalev as the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor ...
SOMERSET, Wis. (WCCO) — Home infusion is meant to help patients become independent and resume normal activities while recovering from an illness. The COVID-19 pandemic jump-started the growth of the ...
Looking for world-class care in OC? Visit Keck Medicine Irvine’s new, expanded multispecialty center on Barranca Pkwy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results